Meckler Jeffrey A
Director; Director, Co-Chief Executive Officer · 4 filings · Latest: Sep 10, 2026
Indaptus Therapeutics, Inc.
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Meckler Jeffrey A | Director | Sep 10, 2026 | Sale | $67.31 | 20,000 | $1.3M | 91,500 | |
TVTX | Meckler Jeffrey A | Director | Sep 10, 2026 | Option Exercise | $21.98 | 20,000 | $439.6K | 111,500 | |
TVTX | JEFFREY MECKLER | — | Sep 10, 2026 | Proposed Sale | $66.22 | 20,000 | $1.3M | — | |
TVTX | Meckler Jeffrey A | Director | May 4, 2026 | Sale | $45.00 | 8,000 | $360.0K | 87,500 | |
TVTX | Meckler Jeffrey A | Director | May 4, 2026 | Option Exercise | $16.33 | 8,000 | $130.6K | 95,500 | |
TVTX | JEFFREY MECKLER | — | May 4, 2026 | Proposed Sale | $45.00 | 8,000 | $360.0K | — | |
TVTX | JEFFREY MECKLER | — | Sep 30, 2024 | Proposed Sale | $14.06 | 40,000 | $562.3K | — |